cytarabine has been researched along with Fibrosarcoma in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (72.73) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidovich, IA; Levenson Chernokhvostov, VV; Levenson, AS | 1 |
| Endo, Y; Fukushima, M; Ito, M; Murata, D; Natsume, N; Obata, T; Sakamoto, K; Sasaki, T; Yamada, Y; Yamasaki, Y | 1 |
| Grdina, DJ; Peters, LJ; Sigdestad, CP | 1 |
| Fujita, H | 1 |
| Koike, S; Todoroki, T; Tsunemoto, H; Watanabe, I | 1 |
| Atkinson, TG; Berry, DM; Meckling-Gill, KA; Murray, L; Ruthig, DJ | 1 |
| Endo, Y; Matsuda, A; Obata, T; Sasaki, T; Tanaka, M | 1 |
| Endo, Y; Matsuda, A; Obata, T; Sasaki, T; Tanaka, M; Uchida, H | 1 |
| Karon, M; Lee, T; Monparler, RL | 1 |
| Goodman, J; Karon, M; Momparler, RL | 1 |
| Benedict, WF; Khwaja, TA | 1 |
| Goodman, J; Momparler, RL | 1 |
| Baker, MS; Benedict, WF; Jones, PA | 1 |
| Benedict, WF; Kouri, RE; Mark, C; Rucker, N | 1 |
| Alvarado, C; Camitta, B; Fernbach, DJ; Krischer, J; Mahoney, DH; Tebbi, CK | 1 |
| Alexander, RB; Coffey, DS; Nelson, WG | 1 |
| Jones, PA; Liu, L; Nyce, J | 1 |
| Ariatti, M; Jones, PA | 1 |
| Durham, JP; Ives, DH | 1 |
| Cabiness, JR; Shullenberger, CC; Sinkovics, JG | 1 |
| Lamerton, LF | 1 |
| Bruce, WR; Lin, H | 1 |
1 trial(s) available for cytarabine and Fibrosarcoma
| Article | Year |
|---|---|
Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group study.
Topics: Child; Cytarabine; Drug Administration Schedule; Fibrosarcoma; Humans; Infusions, Intravenous; Nausea; Neoplasms; Neuroblastoma; Pilot Projects; Rhabdomyosarcoma; Vomiting | 1990 |
21 other study(ies) available for cytarabine and Fibrosarcoma
| Article | Year |
|---|---|
Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance.
Topics: Antifungal Agents; Antimetabolites, Antineoplastic; Apoptosis; Cycloheximide; Cytarabine; DNA Damage; Drug Resistance, Neoplasm; Fibrosarcoma; Genes, Suppressor; GPI-Linked Proteins; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 10c; Survivin; Tumor Cells, Cultured; Tumor Necrosis Factor Decoy Receptors | 2004 |
Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Cell Membrane; Cell Proliferation; Cytarabine; Cytidine; Equilibrative Nucleoside Transport Proteins; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Fibrosarcoma; Green Fluorescent Proteins; Humans; Nucleoside Transport Proteins; RNA, Messenger; Stomach Neoplasms; Tumor Cells, Cultured | 2007 |
Cytotoxic effect in vivo of selected chemotherapeutic agents on synchronized murine fibrosarcoma cells.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cell Cycle; Cell Survival; Cisplatin; Cyclophosphamide; Cytarabine; Cytological Techniques; Doxorubicin; Female; Fibrosarcoma; Mice; Mice, Inbred C3H; Sarcoma, Experimental | 1980 |
[Chemical modification of anticancer agents from viewpoints of their pharmacokinetics].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cytarabine; Doxorubicin; Fibrosarcoma; Fluorouracil; Kinetics; Mice; Mitomycin; Mitomycins; Rabbits; Sarcoma, Experimental; Tegafur | 1984 |
Enhanced radiation lethality in partially synchronized solid mouse tumors.
Topics: Animals; Cell Cycle; Cell Line; Cell Survival; Cytarabine; DNA Replication; Female; Fibrosarcoma; Kinetics; Male; Mice; Mice, Inbred Strains; Mitotic Index; Sarcoma, Experimental | 1982 |
DHA feeding provides host protection and prevents fibrosarcoma-induced hyperlipidemia while maintaining the tumor response to araC in Fischer 344 rats.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow; Cholesterol; Cytarabine; Dietary Fats, Unsaturated; Docosahexaenoic Acids; Fatty Acids; Fibrosarcoma; Hyperlipidemias; Intestines; Male; Organ Size; Rats; Rats, Inbred F344; Safflower Oil; Triglycerides | 1997 |
Development and biochemical characterization of a 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC)-resistant variant of the human fibrosarcoma cell line HT-1080.
Topics: Antimetabolites, Antineoplastic; Cytarabine; Deoxycytidine Kinase; DNA, Neoplasm; Drug Resistance, Neoplasm; Fibrosarcoma; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes; Humans; RNA, Neoplasm; Tumor Cells, Cultured | 1998 |
Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides.
Topics: Antimetabolites, Antineoplastic; Cytarabine; Deoxycytidine; Deoxycytidine Kinase; Drug Resistance, Neoplasm; Fibrosarcoma; Gene Deletion; Gene Expression; Humans; Inhibitory Concentration 50; Melanoma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2001 |
Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
Topics: Animals; Azacitidine; Binding, Competitive; Cells, Cultured; Cricetinae; Cytarabine; Cytidine; Deoxycytidine; Drug Resistance; Fibrosarcoma; Kinetics; Leukemia, Experimental; Mice; Phosphorus; Sarcoma, Experimental | 1975 |
In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.
Topics: Antineoplastic Agents; Azacitidine; Cell Division; Cells, Cultured; Cytarabine; DNA, Neoplasm; Drug Combinations; Fibrosarcoma; Time Factors | 1975 |
A new hamster fibrosarcoma model for in vitro/in vivo evaluation of cancer chemotherapeutic agents.
Topics: Ancitabine; Animals; Antineoplastic Agents; Azacitidine; Cell Division; Cell Line; Cells, Cultured; Clone Cells; Cricetinae; Cytarabine; Disease Models, Animal; Drug Therapy, Combination; Female; Fibrosarcoma; Mesocricetus; Sarcoma, Experimental | 1976 |
Relationship of nutritional factors to in vitro tumor cell growth and cytotoxicity produced by cytosine arabinoside.
Topics: Animals; Cell Division; Cell Line; Cricetinae; Cytarabine; DNA, Neoplasm; Fibrosarcoma; Isoleucine | 1977 |
The effect of 1-beta-D-arabinofuranosylcytosine on cell viability, DNA synthesis, and chromatid breakage in synchronized hamster fibrosarcoma cells.
Topics: Animals; Cell Line; Cell Survival; Chromatids; Cricetinae; Cytarabine; DNA, Neoplasm; Dose-Response Relationship, Drug; Fibrosarcoma; Mitosis; Molecular Weight; Sarcoma, Experimental; Thymidine; Thymine Nucleotides | 1976 |
Correlation between balance of specific chromosomes and expression of malignancy in hamster cells.
Topics: Animals; Animals, Newborn; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Chromosome Aberrations; Cricetinae; Cytarabine; Fibrosarcoma; Karyotyping; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosamines; Transplantation, Homologous | 1975 |
Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II.
Topics: Animals; Bleomycin; Cell Line; Cell Survival; Cytarabine; Dactinomycin; DNA Topoisomerases, Type II; Doxorubicin; Drug Synergism; Etoposide; Fibrosarcoma; Glycoproteins; Hydroxyurea; Mice; Recombinant Proteins; Teniposide; Tumor Necrosis Factor-alpha | 1987 |
Variable effects of DNA-synthesis inhibitors upon DNA methylation in mammalian cells.
Topics: Animals; Aphidicolin; Base Sequence; Cell Line; Chromatography, High Pressure Liquid; Cricetinae; Cycloheximide; Cytarabine; Dactinomycin; Diterpenes; DNA; DNA Polymerase II; DNA Replication; Fibrosarcoma; Hydroxyurea; Methylation; Nalidixic Acid; Novobiocin | 1986 |
N4-chloroacetylcytosine arabinoside--a possible pro-drug of cytosine arabinoside.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; Cytarabine; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Fibrosarcoma; Prodrugs; Sarcoma, Experimental | 1987 |
Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation.
Topics: Adenocarcinoma; Animals; Carcinoma, Hepatocellular; Cattle; Chick Embryo; Chromatography, Ion Exchange; Cytarabine; Cytosine Nucleotides; Deoxyuridine; Escherichia coli; Fibrosarcoma; Kinetics; Leukemia L1210; Leukemia, Experimental; Liver Neoplasms; Lymphoid Tissue; Mice; Mitosis; Neoplasms, Experimental; Nucleosides; Nucleotides; Phosphotransferases; Rats; Thymidine; Thymus Gland | 1969 |
Disappearance after chemotherapy of blocking serum factors as measured in vitro with lymphocytes cytotoxic to tumor cells.
Topics: Adolescent; Carcinoma, Squamous Cell; Cell Line; Chondrosarcoma; Cytarabine; Cytotoxicity Tests, Immunologic; Female; Fibrosarcoma; Humans; Immunity, Cellular; Liposarcoma; Lung Neoplasms; Lymphocytes; Male; Neoplasm Metastasis; Neoplasms; Osteitis Deformans; Osteosarcoma; Rhabdomyosarcoma | 1972 |
Cell proliferation and the differential response of normal and malignant tissues. Silvanus Thompson Memorial Lecture.
Topics: Animals; Blood Vessels; Busulfan; Cell Survival; Cyclophosphamide; Cytarabine; Diffusion; Epithelial Cells; Epithelium; Fibrosarcoma; Hematopoietic Stem Cells; Intestine, Small; Leukemia L1210; Leukemia, Experimental; Methotrexate; Mice; Mitosis; Necrosis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Oxygen; Radiation Effects; Rats | 1972 |
Chemotherapy of the transplanted KHT fibrosarcoma in mice.
Topics: Animals; Antineoplastic Agents; Biological Assay; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Cyclophosphamide; Cytarabine; Drug Synergism; Female; Fibrosarcoma; Hematopoietic Stem Cells; Lung Neoplasms; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Ultracentrifugation; Vinblastine | 1972 |